<i>UGT1A6</i> - and <i>UGT2B7</i> -Related Valproic Acid Pharmacogenomics According to Age Groups and Total Drug Concentration Levels - Concepedia

Concepedia

Publication | Closed Access

<i>UGT1A6</i> - and <i>UGT2B7</i> -Related Valproic Acid Pharmacogenomics According to Age Groups and Total Drug Concentration Levels

16

Citations

45

References

2016

Year

Dimitrios Chatzistefanidis, Leandros Lazaros, Katerina Giaka, Iliada Nakou, Meropi Tzoufi, Ioannis Georgiou, Athanassios P. Kyritsis, Sofia Markoula

Pharmacogenomics

Abstract

UGT1A6 and UGT2B7 genotypes were not related to significant changes in VPA metabolism, even after controlling for total drug concentration levels. Younger ages were associated with increased VPA clearance rate.

References

	Year	Citations
Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Mitchell D. Green, Christopher D. King, B. Mojarrabi, PubMed Bioorganic ChemistryAldo-keto ReductaseOther XenobioticsTertiary Amine MoietyGlycobiology	1998	258
EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Drug Metabolism and Disposition	2003	247
Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance C. Ramana Bhasker, Wendy McKinnon, Andrew N. Stone, Pharmacogenetics GeneticsGenetic EpidemiologyHuman PolymorphismPathologyMolecular Biology	2000	246
Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. Chunjing Jin, John O. Miners, K.J. Lillywhite, Journal of Pharmacology and Experimental Therapeutics	1993	229
Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Thomas Ebner, Brian Burchell Drug Metabolism and Disposition	1993	206
Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications Marco Ciotti, Aldo Marrone, Christine Potter, Pharmacogenetics	1997	192
3′-azido-3′-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7) Olivier Barbier, David Turgeon, Caroline Girard, Drug Metabolism and Disposition	2000	173
Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients M. S. T. van Holthe, T N Rakvåg, Pål Klepstad, The Pharmacogenomics Journal Udp-glucuronosyltransferase 2B7MedicineGeneticsHuman PolymorphismPathology	2003	163
Effect of Aging on Glucuronidation of Valproic Acid in Human Liver Microsomes and the Role of UDP-Glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10 Upendra A. Argikar, Rory P. Remmel Drug Metabolism and Disposition	2008	129
Pharmacokinetics, drug interactions, and tolerability of valproate. PubMed Drug InteractionsMedicinal ChemistryDivalproex SodiumPharmacokinetic ModelingPsychiatry	2003	114

Page 1